PYRAZOLOPYRIMIDONE AND PYRAZOLOPYRIDONE INHIBITORS OF TANKYRASE
申请人:Genentech, Inc.
公开号:US20130345215A1
公开(公告)日:2013-12-26
There are provided compounds of the formula
or a pharmaceutically acceptable salt thereof, wherein Q, R
1
and R
2
are as defined herein.
The compounds of formula I are useful in the treatment of cancer.